index - Thérapie génique pour la DMD & physiopathologie du muscle squelettique Accéder directement au contenu

Dernières publications

Chiffres clés

48 Publications avec texte intégral

Open Access

67 %

Mots clés

Animal/physiopathology Epigenetics Inhibitors Cells Hear Antisense oligonucleotides LncRNA Animals LncARN Multi exon skipping Cultured Ex-vivo Becker BMD muscular dystrophy Calcium Dynamin 2 CD38 Muscular Atrophy Hepatocellular carcinoma Duchenne muscular dystrophy DMD Gene modifiers Invivo CaVβs MES Gene Expression Regulation/drug effects Human Umbilical Vein Endothelial Cells Cell Biology DMD Male L-Type Knockout Duchenne DMD dystrophy Muscle Biology BMD Myogenesis NNOS Skeletal muscle Molecular docking Inbred mdx Muscle Mice Becker muscular dystrophy BMD Myotendinous junction Multi resolution modeling Calcium Channels Muscular Dystrophy Multiresolution modeling DMO Dystrophie musculaire de Becker Cell Line Muscular dystrophy Génomique Autophagy CaV subunits Dystrophin-EGFP Liver Dystrophin Clinical trials Energy Metabolism/drug effects Duchenne muscular dystrophy Mitochondrial fission Becker muscular dystrophy Muscle development Diseases Dystrophine DHPR α1S Morphogenesis Allele‐specific silencing therapy Exon skipping Cardiomyopathy Muscle Strength CTNNB1 NAD+ Dystrophy Homeostasis Metabolism LKB1 Modificateurs de gènes Genomic Gene expression Becker muscular dystrophy BMD Duchenne muscular dystrophy DMD miRNA nNOS Cell homeostasis MiARN Cachexia Dystrophie Musculaire de Becker BMD Muscles/physiopathology Mdx mouse Long noncoding RNA Inbred C57BL Dystrophin central domain Molecular Sequence Data Immunoglobulin Fc Fragments/pharmacology Delivery Humans Dystrophie Musculaire de Duchenne DMD Long QT Drp1 Centronuclear myopathy Base Sequence Activin Receptors Cardiomyopathie